1. Home
  2. AVDL vs SUPX Comparison

AVDL vs SUPX Comparison

Compare AVDL & SUPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.51

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

SUPX

Super X AI Technology Limited Ordinary Shares

SELL

Current Price

$13.61

Market Cap

1.7B

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
AVDL
SUPX
Founded
2015
2021
Country
Ireland
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
AVDL
SUPX
Price
$21.51
$13.61
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$18.38
N/A
AVG Volume (30 Days)
1.6M
295.4K
Earning Date
03-02-2026
10-24-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$248,517,000.00
$3,596,575.00
Revenue This Year
$65.47
N/A
Revenue Next Year
$30.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
79.88
23.88
52 Week Low
$6.38
$3.55
52 Week High
$23.57
$76.50

Technical Indicators

Market Signals
Indicator
AVDL
SUPX
Relative Strength Index (RSI) 56.85 34.27
Support Level $21.45 $13.43
Resistance Level $21.60 $14.85
Average True Range (ATR) 0.08 1.10
MACD -0.05 0.78
Stochastic Oscillator 48.78 8.50

Price Performance

Historical Comparison
AVDL
SUPX

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About SUPX Super X AI Technology Limited Ordinary Shares

Super X AI Technology Ltd is an AI infrastructure solutions provider. Through its subsidiaries, SuperX offers a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, High-Voltage Direct Current (HVDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. The Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments.

Share on Social Networks: